4//SEC Filing
VASCULAR SOLUTIONS INC 4
Accession 0001140361-17-008624
CIK 0001030206operating
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:32 PM ET
Size
9.7 KB
Accession
0001140361-17-008624
Insider Transaction Report
Form 4
ROOT HOWARD
DirectorCEO
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2017-02-17−360,000→ 0 totalExp: 2022-01-27→ Common Stock (360,000 underlying) - Disposition to Issuer
Common Stock
2017-02-17−319,772→ 0 total
Holdings
- 319,772
Common Stock
Footnotes (5)
- [F1]In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.
- [F2]90,000 shares, which vested on January 27, 2014 with an exercise price of $12.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $43.97 per share, or $3,957,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.
- [F3]90,000 shares, which vested on January 27, 2015 with an exercise price of $13.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $42.97 per share, or $3,867,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.
- [F4]90,000 shares, which vested on January 27, 2016 with an exercise price of $14.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $41.97 per share, or $3,777,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.
- [F5]90,000 shares, which vested on January 27, 2017 with an exercise price of $15.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $40.97 per share, or $3,687,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.
Documents
Issuer
VASCULAR SOLUTIONS INC
CIK 0001030206
Entity typeoperating
IncorporatedMN
Related Parties
1- filerCIK 0001030206
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:32 PM ET
- Size
- 9.7 KB